245 related articles for article (PubMed ID: 23355106)
1. Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.
Teguh DN; Levendag PC; Ghidey W; van Montfort K; Kwa SL
Dysphagia; 2013 Sep; 28(3):388-94. PubMed ID: 23355106
[TBL] [Abstract][Full Text] [Related]
2. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
3. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer.
Teguh DN; Levendag PC; Noever I; Voet P; van der Est H; van Rooij P; Dumans AG; de Boer MF; van der Huls MP; Sterk W; Schmitz PI
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):711-6. PubMed ID: 19386439
[TBL] [Abstract][Full Text] [Related]
4. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
[TBL] [Abstract][Full Text] [Related]
5. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
[TBL] [Abstract][Full Text] [Related]
6. Reducing Late Dysphagia for Head and Neck Cancer Survivors with Oral Gel: A Feasibility Study.
Kaae JK; Spejlborg ML; Spork U; Bjørndal K; Eriksen JG
Dysphagia; 2020 Apr; 35(2):231-241. PubMed ID: 31073746
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
[TBL] [Abstract][Full Text] [Related]
8. Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy.
Huynh TTM; Aass HCD; Falk RS; Astrup GL; Helland Å; Bjøro T; Bjordal K; Dale E; Hellebust TP; Herlofson BB; Malinen E; Kiserud CE; Osnes T; Amdal CD
J Cancer Surviv; 2023 Aug; 17(4):1082-1093. PubMed ID: 36350483
[TBL] [Abstract][Full Text] [Related]
9. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
van der Laan HP; Bijl HP; Steenbakkers RJ; van der Schaaf A; Chouvalova O; Vemer-van den Hoek JG; Gawryszuk A; van der Laan BF; Oosting SF; Roodenburg JL; Wopken K; Langendijk JA
Radiother Oncol; 2015 Apr; 115(1):56-62. PubMed ID: 25792467
[TBL] [Abstract][Full Text] [Related]
10. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires.
Steen-Olsen EB; Stormoen DR; Kristensen CA; Vogelius IR; Holländer-Mieritz C; Pappot H
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4199-4206. PubMed ID: 35357578
[TBL] [Abstract][Full Text] [Related]
12. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
[TBL] [Abstract][Full Text] [Related]
13. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
14. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
[TBL] [Abstract][Full Text] [Related]
15. The relationships between xerostomia and dysphagia after chemoradiation of head and neck cancer.
Eisbruch A; Terrell JE
Head Neck; 2003 Dec; 25(12):1082; author reply 1082-3. PubMed ID: 14648868
[No Abstract] [Full Text] [Related]
16. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
17. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
[TBL] [Abstract][Full Text] [Related]
18. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
19. IMRT for head and neck cancer: reducing xerostomia and dysphagia.
Wang X; Eisbruch A
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i69-i75. PubMed ID: 27538846
[TBL] [Abstract][Full Text] [Related]
20. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.
Guillen-Sola A; Soler NB; Marco E; Pera-Cegarra O; Foro P
Trials; 2019 Aug; 20(1):503. PubMed ID: 31412947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
